Advaxis, Inc. (OTC:ADXS) will participate at the Biotech Showcase Healthcare Conference on January 12-13. The conference will be held at the Marines Memorial Club & Hotel in San Francisco. The Biotech Showcase invites life science investors, analysts, business development executives and professional advisors to hear from and meet with management of over 100 early and late stage private and small cap public and private therapeutics, discovery, diagnostic, device and other companies with a focus on the life sciences sector. For more information regarding the event, visit http://www.biotechshowcase.com/.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
Advaxis, Inc., formerly Great Expectations, Inc., is a development-stage biotechnology company focused on developing cancer vaccines that utilize mechanisms of immunity. The Company uses the Listeria system licensed from the University of Pennsylvania (Penn) to secrete a protein sequence containing a tumor-specific antigen. The Company has focused its initial development efforts upon cancer vaccines targeting cervical, head and neck, breast, prostate, and other cancers. Its products in development include Lovaxin C and Lovaxin B, Lovaxin P.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
